Objective: This study was conducted to critically evaluate the drug promotional literature pertaining to drugs used in cardiovascular disorders using WHO criteria for ethical promotion of drugs. Methods: The brochures were collected from physicians to whom it was circulated by the pharmaceutical representatives. These promotional literatures are tested against WHO criteria for the ethical medicinal drug promotion. Results: A total of 309 drug promotional literature pertaining to cardiovascular drugs collected. Analysis of these literatures showed that none of the promotional literature fulfilled all the WHO criteria. All the materials mentioned INN and the brand name of the product. The criteria presented least were information about adjuvants, overdosage and cost of the drug. Conclusion: None of the promotional literatures fulfilled all the WHO criteria laid down for the ethical promotion of drugs.
|Number of pages||3|
|Journal||International Journal of Pharmacy and Pharmaceutical Sciences|
|Publication status||Published - 01-01-2015|
All Science Journal Classification (ASJC) codes
- Pharmaceutical Science